What is the risk of bowel perforation associated with bevacizumab therapy in ovarian cancer?
- 1 April 2007
- journal article
- editorial
- Published by Elsevier in Gynecologic Oncology
- Vol. 105 (1) , 3-6
- https://doi.org/10.1016/j.ygyno.2007.01.038
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: